BRIEF-Neurocrine Biosciences establishes wholesale acquisition cost for a 30-count bottle of Ingrezza 80mg capsules at $6,225
October 05, 2017 at 08:59 AM EDT
* Neurocrine Biosciences Inc says has established wholesale acquisition cost for a 30-count bottle of Ingrezza 80 mg capsules at $6,225 - SEC filing Source text: (http://bit.ly/2y3e9oH) Further company coverage:
